A new form of therapy of experimental tumors, utilizing lymphokineactivated killer (LAK) cells and high doses of interleukin 2, has recently been applied in the treatment of human neoplasms. Severe side effects, suggestive of a diffuse vascular injury of unknown etiology, have pre vented a more widespread application of this form of therapy. We have investigated the etiology of this clinical ca...

A new form of therapy of experimental tumors, utilizing lymphokine-activated killer (LAK) cells and high doses of interleukin 2, has recently been applied in the treatment of human neoplasms. Severe side effects, suggestive of a diffuse vascular injury of unknown etiology, have prevented a more widespread application of this form of therapy. We have investigated the etiology of this clinical ca...

A new form of therapy of experimental tumors, utilizing lymphokineactivated killer (LAK) cells and high doses of interleukin 2, has recently been applied in the treatment of human neoplasms. Severe side effects, suggestive of a diffuse vascular injury of unknown etiology, have pre vented a more widespread application of this form of therapy. We have investigated the etiology of this clinical ca...

The captions for Figs 1 and 2 are switched. The caption that appears with Fig 1 corresponds to Fig 2, and the caption that appears with Fig 2 corresponds to Fig 1. Please see the figures with the appropriate captions below. article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the o...